Simple research view

TECH · Bio-Techne Corp

$71.62 latest stored close

Detected setup Trend Only

Watch · Quality 82/100

Ask about TECH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$TECH

Bio-Techne Corp

Bio-Techne Corp is a large-cap Biotechnology company in the Health Technology sector with a market cap of $11B.

Strong Buy · 82 Health Technology Biotechnology stock Stage 2 · Advancing Base 1 Data 1h 57m ago

$71.62 latest close

← Back Join to Watchlist $TECH Share card

Council read · 6 methods

Watch — evidence is building

0 buyable · 4 watch · 2 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart

Earnings-risk mode

Pre-earnings setup

Wednesday, August 5, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

TECH+0.03%

Sector proxy · XLV+0.51%

Broad market · SPY+0.02%

Same completed session window ending 2026-07-27. TECH was -0.48 points vs XLV. +0.01 points vs SPY.

CatalystUnavailable Stock reactionPositive Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.

Price $71.62 Jul 27 close

52W High $72.16 -0.7%

52W Low $43.19

Wks Since High 25w

Base Depth -40.1%

Tight Wks 4

Base B1

SMA 50 $60.14

SMA 200 $59.38

Avg Vol 5,138,134

RS Rank 61

RS vs High -7.0%

RS Slope +1.3% ▲

Grp Rank #36/64

ADR% 0.6%

ATR(14) $0.40 (0.6%)

Rel Vol (today) 0.74×

Vol Pace N/A

U/D Vol 1.46

A/D Days 6A / 6D

A/D Rating C

VDU Bars 0/10 d

Power Trend 27d

Earnings 8d

$43.19

$72.16 98%

TECH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for TECH.

Create Free Account

Setup Quality B 4/7 signals

Score trend

✓ Stage 2 · Advancing ✓ Power Trend 27d ✗ RS New High ✓ Trend 6/8 ✗ No Pattern ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$TECH · $71.62 · as of 2026-07-27 · multi-factor read

/ 100

Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$60.14 ↑

100-day$56.83 ↑

200-day$59.38 ↑

Golden Cross (fresh)

RSI (14)

Reading73.3 · Overbought

Overbought — buyers extended; watch for a pause or pullback.

MACD (12/26/9)

StateWeakening

Histogram-0.668

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width68% · 2.4%

Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.46 · Neutral

Rel volume0.74×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $72.1452-week high

Price · $71.62now

S · $70.49swing level

S · $61.69swing level

S · $58.40swing level

Fibonacci · Uptrend swing

23.6%$65.29

38.2%$61.07

50.0%$57.66

61.8%$54.24

78.6%$49.38

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for TECH — plus the full 495-symbol scanner and Ask-the-Legends chat.

🔒 Start your 7-day free trial →

Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRSI overbought

Want this read in a legend's voice? 💬 Ask a Legend about TECH

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 4 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Avoid

Minervini D

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $71.62, MA150 $58.82, MA200 $59.38

1.4 50-day MA > 150-day MA AND 200-day MAMA50 $60.14, MA150 $58.82, MA200 $59.38

Failing evidence

1.2 150-day MA > 200-day MAMA150 $58.82 vs MA200 $59.38

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 59

5/10 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

N: Near 52-week high or RS line new high0.7% below high | RS line new high: False

S: Base tightness (ATR% ≤ 4.5%)ATR% 0.56%

Failing evidence

C: Quarterly EPS acceleration ≥ 25%+15.2% QoQ

L: RS rank ≥ 80 (IBD leadership)RS rank 59

2/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $71.62 vs MA200 $59.38

Failing evidence

Volume expansion above averageVolume ratio 0.74x

Relative strength ≥ 60RS 59

5/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$71.62

Distance from 52-week high0.7% below high

Failing evidence

Relative strengthRS 59

Volume vs average0.74x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$71.62

Distance from 52-week high0.7% below high

Failing evidence

Relative strengthRS 59

Volume vs average0.74x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$71.62

Distance from 52-week high0.7% below high

Failing evidence

Relative strengthRS 59

Volume vs average0.74x

3/6 checks

Method → Playbook → Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +6 C

Minervini · Grade Card

Fundamentals & leadership quality — Minervini SEPA criteria · 3/7 met

C 3/7 SEPA

Separate score from the 8-point Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ +15%

✗ Revenue growth ≥20% YoY +5%

✓ Gross margin ≥30% 66%

✗ ROE ≥17% 5%

✗ RS rating ≥80 (leadership) 59

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -0.7%

Method Playbook

📋 Trade it like Minervini EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Minervini D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.

Pivot

Pro level

Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Trend Only

81.7 score

RS Score 59

Trend 6/8 ✓

Why This Setup?

Trend Only

Gatekeeper 6/8 | Moderate trend (6/8) | Power Trend | Stage 2 | Tight base (4 tight wks)

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met

In a confirmed uptrend Stage 2 · Trend 6/8
Risk is defined No stop — undefined risk
Asymmetric reward No target set
Not chasing (in range) Pivot distance unknown
Volume confirms 0.7× average — light
Clear of earnings in 8 days — size down
A relative-strength leader RS 61 — middling

Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $71.62 vs SMA150 $58.82 / SMA200 $59.38

SMA 150 above SMA 200 SMA150 $58.82 vs SMA200 $59.38

SMA 200 trending up Slope +1.68 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $60.14

Price above SMA 50 $71.62 vs SMA50 $60.14

30%+ above 52W low +65.8% from $43.19

Within 25% of 52W high -0.7% from $72.16

RS score above 70 RS 59

Fundamentals

52W Range

98%

Mkt Cap SEC

11.2B

EPS QoQ

+15%

Rev YoY

+5%

ROE

Gross Margin

66%

D/E

0.18

EPS TTM

$0.46

P/E TTM

155.7x

Float

157M

Insider

No Buy

Company

Legend AI snapshot

Bio-Techne Corp

TECH · NASDAQ · Health Technology · Biotechnology

$71.62latest close $11.2Bmarket cap 61RS rank 82setup score

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

7/8

W. RS

W. Support

$43.19

W. Resist

$72.12

Weekly Structure

Trend Rising

Tight Weeks 4

Confirmation Constructive

Scan History

20× streak

Jul 28

Trend Only ✓ Gate

Jul 28

Trend Only ✓ Gate

Jul 28

Trend Only ✓ Gate

Jul 27

Trend Only ✓ Gate

83 0.0%

Jul 27

Trend Only ✓ Gate

83 0.0%

Jul 24

Three Weeks Tight ✓ Gate

90 0.0%

Get the full picture on TECH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial